This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.
Device | P200013S007 |
Classification Name | None |
Applicant | |
PMA | P200013 |
Supplement | S007 |
Supplement Number | Date | Supplement Type |
---|---|---|
P200013 | Original Filing | |
S012 | 2022-12-20 | 30-day Notice |
S011 | 2022-12-07 | Special (immediate Track) |
S010 | ||
S009 | 2022-09-21 | Special (immediate Track) |
S008 | 2022-05-10 | 30-day Notice |
S007 | ||
S006 | 2022-02-17 | 30-day Notice |
S005 | 2021-04-15 | Real-time Process |
S004 | 2021-02-05 | 30-day Notice |
S003 | 2021-02-05 | 30-day Notice |
S002 | ||
S001 | 2020-12-21 | 30-day Notice |